Wellington Management Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7M | Sell |
1,513,478
-80,200
| -5% | -$1.2M | ﹤0.01% | 925 |
|
|
2025
Q1 | $25.7M | Sell |
1,593,678
-10,830
| -0.7% | -$175K | ﹤0.01% | 881 |
|
|
2024
Q4 | $37.4M | Buy |
1,604,508
+97,308
| +6% | +$2.27M | 0.01% | 789 |
|
|
2024
Q3 | $44.3M | Buy |
1,507,200
+711,254
| +89% | +$20.9M | 0.01% | 732 |
|
|
2024
Q2 | $18.7M | Sell |
795,946
-16,914
| -2% | -$398K | ﹤0.01% | 975 |
|
|
2024
Q1 | $30.8M | Buy |
812,860
+177,405
| +28% | +$6.73M | 0.01% | 846 |
|
|
2023
Q4 | $13.7M | Buy |
635,455
+335,526
| +112% | +$7.22M | ﹤0.01% | 1031 |
|
|
2023
Q3 | $3.67M | Sell |
299,929
-52,838
| -15% | -$647K | ﹤0.01% | 1357 |
|
|
2023
Q2 | $3.97M | Buy |
+352,767
| New | +$3.97M | ﹤0.01% | 1333 |
|